ANINDYA CARIMA, 051211131062 (2016) STUDI PENGGUNAAN OBAT GOLONGAN β2-AGONIS PADA PASIEN ASMA (Penelitian dilakukan di Instalasi Rawat Jalan Paru RSUD Dr. Soetomo Surabaya). Skripsi thesis, Universitas Airlangga.

Preview	Text (abstrak) FF.FK. 19-16 Car s abstrak.pdf Download (1MB) | Preview
Preview	Text (FULLTEXT) FF.FK. 19-16 Car s-min.pdf Download (1MB) | Preview

Abstract

Background. Asthma is a hetergenous disease and usually characterized by chronic airway inflamation. Another study declare that prevalence of asthma in Indonesia were increased. There are many benefit from use β2- agonist drug for asthma treatment because it has bronchodilator and bronchoprotector activity. Objectives.The aim of this study are to identify the utilization of β2-agonist drug in asthma and Drug Related Problems (DRPs) that occur in using β2- agonist drug. Methods. This study has retrospective observasional method by using patient’s Electronic Medical Record(EMR) who are in January-December 2015 period. All data were analyzed by comparedwith Global Initiative for Asthma 2015 (GINA 2015). Results. In this study,there are 34 subjects that appropriate with inclusion criteria. There are44.11% subject use SABA, 8.84% use LABA,47.05% use combination SABA and LABA.β2-agonist drug that mostly used is Salbutamol (SABA) and Formoterol (LABA). β2-agonist drug + corticosteroid is combination therapy that mostly used in this study. There were some administration dose that given by physician according to patient’s condition. Problems that potentially occur in this study are adverse effect and interaction between β2-agonist with corticosteroid 60.49% and with others simpatomimetics agent 39.51%. Conclusion.Drug of choicefor asthma treatment are Salbutamol as reliever therapy and Formoterol as controller therapy. Administration dose that given were appropriate with GINA 2015. None of actual DRPs occured. Keywords. Drug utiliztion study, Asthma, β2-agonist drug, Descriptive analysis

Actions (login required)

View Item